Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPTN
426
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.62M | ﹤0.01% |
223,056
-22,313
| -9% | -$165K |
|
|
LMNX
427
DELISTED
Luminex Corp
LMNX
| $1.61M | ﹤0.01% |
58,613
-8,796
| -13% | -$216K |
|
428
Toll Brothers
TOL
$14.5B
| $1.59M | ﹤0.01% |
82,841
-1,177
| -1% | -$44.5K |
|
429
Stewart Information Services
STC
$2.08B
| $1.56M | ﹤0.01% |
58,394
+12,056
| +26% | +$443K |
|
430
Expeditors International
EXPD
$23.2B
| $1.55M | ﹤0.01% |
23,308
+2,969
| +15% | +$212K |
|
431
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
| $1.52M | ﹤0.01% |
104,972
-149,968
| -59% | -$3.56M |
|
432
Zimmer Biomet
ZBH
$18.4B
| $1.49M | ﹤0.01% |
15,212
-340
| -2% | -$44.6K |
|
433
Columbia Banking Systems
COLB
$8.84B
| $1.48M | ﹤0.01% |
55,248
-5,161
| -9% | -$181K |
|
434
Invesco China Technology ETF
CQQQ
$3.22B
| $1.45M | ﹤0.01% |
30,328
-60,419
| -67% | -$3.25M |
|
435
Northern Trust
NTRS
$33.9B
| $1.45M | ﹤0.01% |
19,204
-2,485
| -11% | -$228K |
|
436
CVB Financial
CVBF
$3.99B
| $1.44M | ﹤0.01% |
72,015
-9,109
| -11% | -$183K |
|
|
JOYY
437
JOYY Inc
JOYY
$3.75B
| $1.44M | ﹤0.01% |
26,972
-7,306
| -21% | -$424K |
|
438
General Dynamics
GD
$106B
| $1.43M | ﹤0.01% |
10,785
-1,886
| -15% | -$313K |
|
439
UnitedHealth
UNH
$370B
| $1.42M | ﹤0.01% |
5,693
-2,403
| -30% | -$661K |
|
440
Heartland Express
HTLD
$956M
| $1.39M | ﹤0.01% |
+75,000
| New | +$1.43M |
|
441
iShares MSCI Spain ETF
EWP
$2.17B
| $1.34M | ﹤0.01% |
66,109
-39,230
| -37% | -$1.02M |
|
|
ANSS
442
DELISTED
Ansys
ANSS
| $1.33M | ﹤0.01% |
5,722
-372
| -6% | -$95.9K |
|
443
Tyson Foods
TSN
$20.4B
| $1.33M | ﹤0.01% |
22,972
+2,584
| +13% | +$193K |
|
444
Valero Energy
VLO
$85.9B
| $1.3M | ﹤0.01% |
28,662
-1,403
| -5% | -$102K |
|
445
Xylem
XYL
$28.1B
| $1.29M | ﹤0.01% |
19,753
-22
| -0.1% | -$1.73K |
|
|
QTS
446
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.28M | ﹤0.01% |
22,057
+155
| +0.7% | +$8.65K |
|
447
Resources Connection
RGP
$145M
| $1.28M | ﹤0.01% |
116,406
-13,690
| -11% | -$186K |
|
448
M/I Homes
MHO
$3.84B
| $1.27M | ﹤0.01% |
77,038
-9,228
| -11% | -$334K |
|
449
Cencora
COR
$61.2B
| $1.27M | ﹤0.01% |
14,355
-947
| -6% | -$83.4K |
|
450
Marriott International
MAR
$92.3B
| $1.27M | ﹤0.01% |
16,969
-502
| -3% | -$62.5K |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.